Back to Search
MARY-ELIZABETH PERCIVAL, M.D.
M.D.
Hematology (Internal Medicine) Physician
NPI: 1225278955IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
A106581(CA)
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
MD.MD.60591746(WA)
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
A106581(CA)
Education
STANFORD UNIVERSITY SCHOOL OF MEDICINE
Class of 2007
Research & Publications (20)
A preliminary retrospective survey of injuries occurring in dogs participating in canine agility.
PMID 19597633·Vet Comp Orthop Traumatol·2009
7-preclinical
Pharmacological inhibitors to identify roles of cathepsin K in cell-based studies: a comparison of available tools.
PMID 19453281·Biol Chem·2009
7-preclinical
Renin and prorenin activate pathways implicated in organ damage in human mesangial cells independent of angiotensin II production.
PMID 19451703·Am J Nephrol·2009
8-other
Development of a homogeneous immunoassay for the detection of angiotensin I in plasma using AlphaLISA acceptor beads technology.
PMID 19258005·Anal Biochem·2009
7-preclinical
Identification of a nonbasic, nitrile-containing cathepsin K inhibitor (MK-1256) that is efficacious in a monkey model of osteoporosis.
PMID 18811135·J Med Chem·2008
7-preclinical
Cleavage of type II collagen by cathepsin K in human osteoarthritic cartilage.
PMID 18511517·Am J Pathol·2008
8-other
The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation.
PMID 18403221·Osteoarthritis Cartilage·2008
8-other
In vivo inhibition of serine protease processing requires a high fractional inhibition of cathepsin C.
PMID 18326050·Mol Pharmacol·2008
4-observational
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K.
PMID 18226527·Bioorg Med Chem Lett·2008
7-preclinical
Effect of cathepsin k inhibitor basicity on in vivo off-target activities.
PMID 17940194·Mol Pharmacol·2008
7-preclinical
Cathepsin K null mice show reduced adiposity during the rapid accumulation of fat stores.
PMID 17668061·PLoS One·2007
7-preclinical
The identification of potent, selective, and bioavailable cathepsin S inhibitors.
PMID 17590332·Bioorg Med Chem Lett·2007
7-preclinical
Primary amides as selective inhibitors of cathepsin K.
PMID 17544269·Bioorg Med Chem Lett·2007
8-other
Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing.
PMID 17535802·J Biol Chem·2007
7-preclinical
Beta-substituted cyclohexanecarboxamide cathepsin K inhibitors: modification of the 1,2-disubstituted aromatic core.
PMID 17408953·Bioorg Med Chem Lett·2007
7-preclinical
The consequences of lysosomotropism on the design of selective cathepsin K inhibitors.
PMID 16921579·Chembiochem·2006
6-review
Identification of a potent and selective non-basic cathepsin K inhibitor.
PMID 16413777·Bioorg Med Chem Lett·2006
7-preclinical
Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity.
PMID 16302795·J Med Chem·2005
7-preclinical
Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K.
PMID 16302794·J Med Chem·2005
7-preclinical
Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K.
PMID 16154747·Bioorg Med Chem Lett·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 825 EASTLAKE AVE E, SEATTLE CANCER CARE ALLIANCE
SEATTLE, WA 98109 - Phone
- (206) 598-6190
Quick Facts
- NPI
- 1225278955
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 19
- Publications
- 20
Are you this provider?
Claim Your Profile